WallStSmart

Focus Universal Inc (FCUV)vsMKS Instruments Inc (MKSI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 577513% more annual revenue ($4.35B vs $752,580). MKSI leads profitability with a 10.1% profit margin vs 0.0%. MKSI earns a higher WallStSmart Score of 69/100 (B-).

FCUV

Avoid

33

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 6.0Quality: 4.5
Piotroski: 3/9Altman Z: -5.27

MKSI

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 4.0Quality: 4.5
Piotroski: 4/9Altman Z: 1.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FCUVUndervalued (+15.6%)

Margin of Safety

+15.6%

Fair Value

$6.36

Current Price

$5.70

$0.66 discount

UndervaluedFair: $6.36Overvalued
MKSISignificantly Overvalued (-59.8%)

Margin of Safety

-59.8%

Fair Value

$162.14

Current Price

$267.31

$105.17 premium

UndervaluedFair: $162.14Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FCUV2 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
1811.0%10/10

Revenue surging 1811.0% year-over-year

MKSI3 strengths · Avg: 8.7/10
EPS GrowthGrowth
162.0%10/10

Earnings expanding 162.0% YoY

Operating MarginProfitability
20.6%8/10

Strong operational efficiency at 20.6%

Revenue GrowthGrowth
28.3%8/10

Revenue surging 28.3% year-over-year

Areas to Watch

FCUV4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$7.98M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.363/10

Elevated debt levels

MKSI3 concerns · Avg: 2.3/10
Debt/EquityHealth
1.403/10

Elevated debt levels

P/E RatioValuation
42.3x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.242/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : FCUV

The strongest argument for FCUV centers on Price/Book, Revenue Growth. Revenue growth of 1811.0% demonstrates continued momentum.

Bull Case : MKSI

The strongest argument for MKSI centers on EPS Growth, Operating Margin, Revenue Growth. Revenue growth of 28.3% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : FCUV

The primary concerns for FCUV are EPS Growth, Market Cap, Profit Margin.

Bear Case : MKSI

The primary concerns for MKSI are Debt/Equity, P/E Ratio, Altman Z-Score. A P/E of 42.3x leaves little room for execution misses.

Key Dynamics to Monitor

FCUV profiles as a hypergrowth stock while MKSI is a growth play — different risk/reward profiles.

MKSI carries more volatility with a beta of 1.97 — expect wider price swings.

FCUV is growing revenue faster at 1811.0% — sustainability is the question.

MKSI generates stronger free cash flow (189M), providing more financial flexibility.

Bottom Line

MKSI scores higher overall (69/100 vs 33/100) and 28.3% revenue growth. FCUV offers better value entry with a 15.6% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Focus Universal Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Focus Universal Inc. develops and manufactures smart instrumentation platforms and devices. The company is headquartered in Ontario, California.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?